In focus · trending topic

SequestOx

16 stories · following the connections

Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study

By Nasdaq OMXJan 30, 2018, 1:36 PM UTC

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017

By Nasdaq OMXNov 9, 2017, 9:59 PM UTC

Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference

By Nasdaq OMXAug 30, 2017, 12:01 PM UTC

Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™

By Nasdaq OMXJul 7, 2017, 4:48 PM UTC

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information

By Nasdaq OMXJun 14, 2017, 8:59 PM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC